Total Payments
$74,673
2024 Payments
$13,974
Companies
53
Transactions
672
Medicare Patients
9,303
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$58,579 (78.4%)
Food & Beverage$13,010 (17.4%)
Travel$2,134 (2.9%)
Research$800.00 (1.1%)
Education$150.18 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,579 | 39 | 78.4% |
| Food and Beverage | $13,010 | 614 | 17.4% |
| Travel and Lodging | $2,134 | 14 | 2.9% |
| Unspecified | $800.00 | 1 | 1.1% |
| Education | $150.18 | 4 | 0.2% |
Payments by Type
General
$73,873
671 transactions
Research
$800.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $63,541 | 145 | $0 (2024) |
| ABBVIE INC. | $1,030 | 54 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $977.03 | 64 | $0 (2021) |
| Amgen Inc. | $829.76 | 73 | $0 (2022) |
| UCB, Inc. | $816.34 | 39 | $0 (2024) |
| Covidien LP | $800.00 | 1 | $0 (2017) |
| Abbott Laboratories | $692.08 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $666.24 | 55 | $0 (2024) |
| Medtronic USA, Inc. | $538.22 | 9 | $0 (2020) |
| Acorda Therapeutics, Inc | $516.75 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,974 | 112 | Teva Pharmaceuticals USA, Inc. ($12,046) |
| 2023 | $17,672 | 60 | Teva Pharmaceuticals USA, Inc. ($16,623) |
| 2022 | $6,871 | 81 | Teva Pharmaceuticals USA, Inc. ($5,453) |
| 2021 | $12,848 | 53 | Teva Pharmaceuticals USA, Inc. ($12,205) |
| 2020 | $4,105 | 50 | Teva Pharmaceuticals USA, Inc. ($3,385) |
| 2019 | $10,267 | 152 | Teva Pharmaceuticals USA, Inc. ($8,642) |
| 2018 | $6,727 | 112 | Teva Pharmaceuticals USA, Inc. ($5,034) |
| 2017 | $2,209 | 52 | Covidien LP ($800.00) |
All Payment Transactions
672 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Immunology | ||||||
| 12/07/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Central Nervous System | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Neurology | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PAIN | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Rare Disease | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: PAIN | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: PAIN | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Central Nervous System | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neurology | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: PAIN | ||||||
| 08/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Sabre Surgeon and nurse Validation | Covidien LP | $800.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,680 | 14,011 | $896,057 | $363,890 |
| 2022 | 20 | 2,336 | 12,283 | $782,107 | $318,821 |
| 2021 | 24 | 2,361 | 10,841 | $784,353 | $338,181 |
| 2020 | 23 | 1,926 | 6,889 | $535,866 | $197,068 |
Total Patients
9,303
Total Services
44,024
Medicare Billing
$1.2M
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,026 | 1,813 | $395,234 | $163,357 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 335 | 402 | $118,188 | $52,217 | 44.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 330 | 330 | $138,930 | $51,663 | 37.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 9,500 | $114,000 | $46,592 | 40.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 73 | $30,295 | $9,816 | 32.4% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2023 | 13 | 900 | $21,600 | $8,835 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 128 | $19,200 | $8,319 | 43.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 52 | $11,076 | $4,889 | 44.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 17 | 33 | $10,593 | $4,027 | 38.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 88 | 98 | $10,584 | $3,941 | 37.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 37 | 61 | $5,063 | $1,948 | 38.5% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 12 | 17 | $4,284 | $1,767 | 41.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 152 | 175 | $2,450 | $1,470 | 60.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 60 | 60 | $2,580 | $886.80 | 34.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 69 | 72 | $2,016 | $685.44 | 34.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 36 | 36 | $1,728 | $592.56 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 37 | 39 | $1,482 | $511.68 | 34.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 30 | 30 | $1,350 | $498.00 | 36.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 28 | 28 | $1,176 | $403.48 | 34.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 11 | $891.00 | $319.11 | 35.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 35 | 35 | $875.00 | $309.40 | 35.4% |
| 82565 | Blood creatinine level | Office | 2023 | 45 | 48 | $720.00 | $240.96 | 33.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 29 | 29 | $638.00 | $220.69 | 34.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 20 | 20 | $600.00 | $207.00 | 34.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 21 | 21 | $504.00 | $174.09 | 34.5% |
About Dr. Ricardo Gonzalez, MD
Dr. Ricardo Gonzalez, MD is a Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063678035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ricardo Gonzalez, MD has received a total of $74,673 in payments from pharmaceutical and medical device companies, with $13,974 received in 2024. These payments were reported across 672 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,579).
As a Medicare-enrolled provider, Gonzalez has provided services to 9,303 Medicare beneficiaries, totaling 44,024 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Sarasota, FL
- Active Since 07/30/2008
- Last Updated 10/17/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063678035
Products in Payments
- AUSTEDO (Drug) $39,103
- Austedo XR (Drug) $23,991
- APTIOM (Drug) $825.22
- Aimovig (Biological) $805.14
- Sonicision (Device) $800.00
- INFINITY (Device) $623.73
- INBRIJA (Drug) $516.75
- ACTIVA (Device) $509.60
- NURTEC ODT (Drug) $406.72
- BOTOX (Biological) $385.56
- Briviact (Drug) $349.04
- QULIPTA (Drug) $319.52
- UBRELVY (Drug) $303.02
- AIMOVIG (Biological) $260.03
- Neupro (Drug) $229.10
- AJOVY (Drug) $221.93
- Leqembi (Drug) $214.84
- RYTARY (Drug) $185.04
- Vimpat (Drug) $183.33
- EMGALITY (Drug) $182.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sarasota
Donald Negroski, Md, MD
Neurology — Payments: $1.8M
Neurology $1.8M
Dr. V Kassicieh, D.o, D.O
Neurology — Payments: $403,795
Neurology $403,795
Mauricio Concha, Md, MD
Neurology — Payments: $274,642
Neurology $274,642
Gregory Hanes, Md, MD
Neurology — Payments: $261,651
Neurology $261,651
Dean Sutherland, Md, MD
Neurology — Payments: $67,914
Neurology $67,914
Dr. Ronald Aung-Din, M.d, M.D
Neurology — Payments: $45,214
Neurology $45,214